NCIt related terms : (2R)-N-Hydroxy-2-[[(4-methoxyphenyl)sulfonyl](3-pyridinylmethyl)amino]-3-methylbutanamide
Monohydrochloride;
NCIt definition : An orally-active synthetic hydroxamic acid derivative with potential antineoplastic
activity. MMI270 inhibits a broad spectrum of matrix metalloproteinases (MMPs) (specifically
MMP-1, 2, 3, 9, and 13), thereby inducing extracellular matrix degradation, and inhibiting
angiogenesis, tumor growth and invasion, and metastasis. This agent may also downregulate
lymphangiogenesis, resulting in decreased lymphatic system-related metastasis. (NCI04);